Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 400 | 427 | 404 | 382 | 309 |
| Accounts receivable | -120 | 395 | -601 | 313 | -798 |
| Other Working Capital | -331 | 604 | -244 | -1,803 | -958 |
| Other Operating Activity | 817 | -22 | 1,280 | 2,447 | -10 |
| Operating Cash Flow | $766 | $1,403 | $839 | $1,339 | $-1,456 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -229 | -732 | -638 | -37 | -118 |
| Purchase Sale Intangibles | 0 | -271 | N/A | N/A | N/A |
| Investing Cash Flow | $-229 | $-1,003 | $-638 | $-37 | $-118 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 0 | 33 |
| Debt Repayment | -73 | -303 | -73 | -73 | -73 |
| Common Stock Repurchased | -315 | -163 | -395 | -53 | -188 |
| Other Financing Activity | 6 | 0 | 357 | 0 | 0 |
| Financing Cash Flow | $-382 | $-465 | $-111 | $-126 | $-229 |
| Beginning Cash Position | 12,809 | 12,873 | 12,783 | 11,606 | 13,409 |
| End Cash Position | 12,963 | 12,809 | 12,873 | 12,783 | 11,606 |
| Net Cash Flow | $155 | $-64 | $90 | $1,176 | $-1,803 |
| Free Cash Flow | |||||
| Operating Cash Flow | 766 | 1,403 | 839 | 1,339 | -1,456 |
| Capital Expenditure | -229 | -1,003 | -638 | -37 | -118 |
| Free Cash Flow | 536 | 401 | 201 | 1,302 | -1,574 |